E Fund Management Co., Ltd.
- SEC CIK
- 0001842296
- Latest filing
- Aug 10, 2026
HRTX holding history
Heron Therapeutics, Inc. in every 13F filed by E Fund Management Co., Ltd., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HRTX overviewAll 13F holders of HRTXFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −15,642−100.0% | Sold out | Holders |
| Q2 2024 | 15,642 | $54.7K | <0.1% | +15,642 | New | Holders |
| Q4 2022 | 0 | $0 | 0.0% | −41,391−100.0% | Sold out | Holders |
| Q3 2022 | 41,391 | $175.0K | <0.1% | −45,190−52.2% | Reduced | Holders |
| Q2 2022 | 86,581 | $242.0K | <0.1% | +38,818+81.3% | Added | Holders |
| Q1 2022 | 47,763 | $273.0K | <0.1% | +29,396+160.0% | Added | Holders |
| Q4 2021 | 18,367 | $168.0K | <0.1% | +3,562+24.1% | Added | Holders |
| Q3 2021 | 14,805 | $158.0K | <0.1% | – | No prior filing | Holders |